- Home
- PMCB vs ARBB Comparison
PMCB vs ARBB Comparison
Compare PMCB & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- ARBB
- Stock Information
- Founded
- PMCB 1996
- ARBB 1997
- Country
- PMCB United States
- ARBB Singapore
- Employees
- PMCB N/A
- ARBB N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- ARBB EDP Services
- Sector
- PMCB Health Care
- ARBB Technology
- Exchange
- PMCB Nasdaq
- ARBB Nasdaq
- Market Cap
- PMCB 13.9M
- ARBB 14.9M
- IPO Year
- PMCB N/A
- ARBB 2023
- Fundamental
- Price
- PMCB $1.64
- ARBB $0.48
- Analyst Decision
- PMCB
- ARBB
- Analyst Count
- PMCB 0
- ARBB 0
- Target Price
- PMCB N/A
- ARBB N/A
- AVG Volume (30 Days)
- PMCB 57.4K
- ARBB 28.5M
- Earning Date
- PMCB 12-13-2024
- ARBB 11-22-2024
- Dividend Yield
- PMCB N/A
- ARBB N/A
- EPS Growth
- PMCB N/A
- ARBB N/A
- EPS
- PMCB 0.54
- ARBB N/A
- Revenue
- PMCB N/A
- ARBB $12,334,474.00
- Revenue This Year
- PMCB N/A
- ARBB N/A
- Revenue Next Year
- PMCB N/A
- ARBB N/A
- P/E Ratio
- PMCB $3.06
- ARBB N/A
- Revenue Growth
- PMCB N/A
- ARBB N/A
- 52 Week Low
- PMCB $1.39
- ARBB $0.22
- 52 Week High
- PMCB $2.58
- ARBB $4.55
- Technical
- Relative Strength Index (RSI)
- PMCB 40.27
- ARBB 46.53
- Support Level
- PMCB $1.72
- ARBB $0.68
- Resistance Level
- PMCB $1.94
- ARBB $1.00
- Average True Range (ATR)
- PMCB 0.17
- ARBB 0.13
- MACD
- PMCB -0.01
- ARBB -0.02
- Stochastic Oscillator
- PMCB 9.27
- ARBB 4.48
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT') and Investment holding and others. It earns its maximum profit from the Internet of Things segment.